Cargando…
Treatment outcomes of sofosbuvir/velpatasvir/voxilaprevir among NS5A inhibitor‐experienced patients with hepatitis C: Real‐world data from a multicenter Asian registry
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543910/ https://www.ncbi.nlm.nih.gov/pubmed/35723645 http://dx.doi.org/10.1111/jgh.15918 |
| _version_ | 1784804481757609984 |
|---|---|
| author | Wong, YJ Kumar, R Kumar, R Tan, J Liu, CH Hui, VW‐K Tan, SS Kao, JH Wong, GL‐H Thurairajah, PH |
| author_facet | Wong, YJ Kumar, R Kumar, R Tan, J Liu, CH Hui, VW‐K Tan, SS Kao, JH Wong, GL‐H Thurairajah, PH |
| author_sort | Wong, YJ |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9543910 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95439102022-10-14 Treatment outcomes of sofosbuvir/velpatasvir/voxilaprevir among NS5A inhibitor‐experienced patients with hepatitis C: Real‐world data from a multicenter Asian registry Wong, YJ Kumar, R Kumar, R Tan, J Liu, CH Hui, VW‐K Tan, SS Kao, JH Wong, GL‐H Thurairajah, PH J Gastroenterol Hepatol Regular Articles John Wiley and Sons Inc. 2022-06-30 2022-08 /pmc/articles/PMC9543910/ /pubmed/35723645 http://dx.doi.org/10.1111/jgh.15918 Text en © 2022 The Authors. Journal of Gastroenterology and Hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Regular Articles Wong, YJ Kumar, R Kumar, R Tan, J Liu, CH Hui, VW‐K Tan, SS Kao, JH Wong, GL‐H Thurairajah, PH Treatment outcomes of sofosbuvir/velpatasvir/voxilaprevir among NS5A inhibitor‐experienced patients with hepatitis C: Real‐world data from a multicenter Asian registry |
| title | Treatment outcomes of sofosbuvir/velpatasvir/voxilaprevir among NS5A inhibitor‐experienced patients with hepatitis C: Real‐world data from a multicenter Asian registry |
| title_full | Treatment outcomes of sofosbuvir/velpatasvir/voxilaprevir among NS5A inhibitor‐experienced patients with hepatitis C: Real‐world data from a multicenter Asian registry |
| title_fullStr | Treatment outcomes of sofosbuvir/velpatasvir/voxilaprevir among NS5A inhibitor‐experienced patients with hepatitis C: Real‐world data from a multicenter Asian registry |
| title_full_unstemmed | Treatment outcomes of sofosbuvir/velpatasvir/voxilaprevir among NS5A inhibitor‐experienced patients with hepatitis C: Real‐world data from a multicenter Asian registry |
| title_short | Treatment outcomes of sofosbuvir/velpatasvir/voxilaprevir among NS5A inhibitor‐experienced patients with hepatitis C: Real‐world data from a multicenter Asian registry |
| title_sort | treatment outcomes of sofosbuvir/velpatasvir/voxilaprevir among ns5a inhibitor‐experienced patients with hepatitis c: real‐world data from a multicenter asian registry |
| topic | Regular Articles |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543910/ https://www.ncbi.nlm.nih.gov/pubmed/35723645 http://dx.doi.org/10.1111/jgh.15918 |
| work_keys_str_mv | AT wongyj treatmentoutcomesofsofosbuvirvelpatasvirvoxilapreviramongns5ainhibitorexperiencedpatientswithhepatitiscrealworlddatafromamulticenterasianregistry AT kumarr treatmentoutcomesofsofosbuvirvelpatasvirvoxilapreviramongns5ainhibitorexperiencedpatientswithhepatitiscrealworlddatafromamulticenterasianregistry AT kumarr treatmentoutcomesofsofosbuvirvelpatasvirvoxilapreviramongns5ainhibitorexperiencedpatientswithhepatitiscrealworlddatafromamulticenterasianregistry AT tanj treatmentoutcomesofsofosbuvirvelpatasvirvoxilapreviramongns5ainhibitorexperiencedpatientswithhepatitiscrealworlddatafromamulticenterasianregistry AT liuch treatmentoutcomesofsofosbuvirvelpatasvirvoxilapreviramongns5ainhibitorexperiencedpatientswithhepatitiscrealworlddatafromamulticenterasianregistry AT huivwk treatmentoutcomesofsofosbuvirvelpatasvirvoxilapreviramongns5ainhibitorexperiencedpatientswithhepatitiscrealworlddatafromamulticenterasianregistry AT tanss treatmentoutcomesofsofosbuvirvelpatasvirvoxilapreviramongns5ainhibitorexperiencedpatientswithhepatitiscrealworlddatafromamulticenterasianregistry AT kaojh treatmentoutcomesofsofosbuvirvelpatasvirvoxilapreviramongns5ainhibitorexperiencedpatientswithhepatitiscrealworlddatafromamulticenterasianregistry AT wongglh treatmentoutcomesofsofosbuvirvelpatasvirvoxilapreviramongns5ainhibitorexperiencedpatientswithhepatitiscrealworlddatafromamulticenterasianregistry AT thurairajahph treatmentoutcomesofsofosbuvirvelpatasvirvoxilapreviramongns5ainhibitorexperiencedpatientswithhepatitiscrealworlddatafromamulticenterasianregistry |